David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Stantec
STN
$8.26B
| $7.3M | 0.01% |
262,800
+26,900
| +11% | +$714K |
|
|
CSGS
1102
DELISTED
CSG Systems International
CSGS
| $7.27M | 0.01% |
181,376
-9,419
| -5% | -$372K |
|
1103
Alpha and Omega Semiconductor
AOSL
$805M
| $7.25M | 0.01% |
439,558
+5,283
| +1% | +$86.5K |
|
1104
PUT
Alaska Air
ALK
$4.84B
| $7.25M | 0.01% |
95,000
+85,000
| +850% | +$6.95M |
|
1105
Bath & Body Works
BBWI
$3.54B
| $7.23M | 0.01% |
214,942
+157,131
| +272% | +$5.27M |
|
1106
Integra LifeSciences
IART
$1.31B
| $7.22M | 0.01% |
143,132
-119,690
| -46% | -$6.15M |
|
1107
Matrix Service
MTRX
$303M
| $7.22M | 0.01% |
475,329
-46,104
| -9% | -$524K |
|
1108
Jabil
JBL
$32.3B
| $7.22M | 0.01% |
+252,880
| New | +$7.65M |
|
1109
Encore Capital Group
ECPG
$2.17B
| $7.22M | 0.01% |
162,916
-10,374
| -6% | -$420K |
|
1110
PUT
Range Resources
RRC
$9.58B
| $7.21M | 0.01% |
368,400
+45,000
| +14% | +$870K |
|
|
OME
1111
DELISTED
Omega Protein
OME
| $7.2M | 0.01% |
432,476
+27,747
| +7% | +$451K |
|
|
KITE
1112
PUT
DELISTED
Kite Pharma, Inc.
KITE
| $7.19M | 0.01% |
+40,000
| New | +$5.57M |
|
1113
PUT
3M
MMM
$92.5B
| $7.18M | 0.01% |
40,903
-25,236
| -38% | -$4.37M |
|
1114
iShares National Muni Bond ETF
MUB
$45.6B
| $7.17M | 0.01% |
64,700
| – | – |
|
|
ALOG
1115
DELISTED
Analogic Corp
ALOG
| $7.16M | 0.01% |
85,543
-10,700
| -11% | -$780K |
|
|
COHR
1116
PUT
DELISTED
Coherent Inc
COHR
| $7.15M | 0.01% |
30,400
-11,300
| -27% | -$2.73M |
|
|
RDS.A
1117
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $7.14M | 0.01% |
117,878
+112,118
| +1,946% | +$6.27M |
|
1118
ATI
ATI
$29.3B
| $7.13M | 0.01% |
298,259
-125,096
| -30% | -$2.47M |
|
1119
Grupo Cibest SA
CIB
$24.4B
| $7.13M | 0.01% |
155,599
-45,698
| -23% | -$2.06M |
|
1120
Principal Financial Group
PFG
$23.9B
| $7.11M | 0.01% |
110,473
+60,092
| +119% | +$3.87M |
|
|
GG
1121
PUT
DELISTED
Goldcorp Inc
GG
| $7.09M | 0.01% |
547,000
-33,900
| -6% | -$446K |
|
1122
PUT
Chemours
CC
$2.37B
| $7.08M | 0.01% |
140,000
+30,000
| +27% | +$1.42M |
|
1123
HUB Group
HUBG
$2.4B
| $7.08M | 0.01% |
329,910
-125,872
| -28% | -$2.4M |
|
1124
G-III Apparel Group
GIII
$1.4B
| $7.07M | 0.01% |
243,527
-79,187
| -25% | -$2.09M |
|
|
KITE
1125
DELISTED
Kite Pharma, Inc.
KITE
| $7.03M | 0.01% |
+39,106
| New | +$5.45M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.